Enhanced FOXO1 expression as a predictor of decitabine response and prolonged survival in high-risk myelodysplastic syndrome

Purpose The aim of this study was to assess the predictive role of FOXO1 expression changes in determining the response to hypomethylation therapy in patients with high-risk myelodysplastic syndrome (MDS).Methods FOXO1 mRNA levels were measured using real-time PCR in 62 newly diagnosed MDS patients...

Full description

Bibliographic Details

Published in:	Hematology
Main Authors:	Hong Liu, Zheng Zhang, Nanfang Huang, Feng Xu, Sida Zhao, Chunkang Chang
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2025-12-01
Subjects:	Myelodysplastic syndromes decitabine treatment response immunity polarization prognosis
Online Access:	https://www.tandfonline.com/doi/10.1080/16078454.2025.2506862